Health Care & Life Sciences » Biotechnology | NewLink Genetics Corp.

NewLink Genetics Corp.

NewLink Genetics Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
37.21 M
Public Float
28.83 M
NewLink Genetics Corp.
Stock Exchange NASDAQ Stock Market
EPS
$1.22
Market Cap
$54.42 M
Shares Outstanding
37.28 M
Public Float
28.76 M

Profile

Address
2503 South Loop Drive
Ames Iowa 50010
United States
Employees -
Website http://www.newlinkgenetics.com
Updated 07/08/2019
NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications.

Financials

View All
Created with Highcharts 5.0.14NewLink Genetics Corp.Net Income. Fiscal year is January-December. All values USD Thousands.31 18031 180102 858102 85840 38140 38185 15585 15571 95171 95153 59553 595201320142015201620172018025k50k75k100k125k
Created with Highcharts 5.0.14NewLink Genetics Corp.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.1 0931 093172 592172 59268 50168 50135 76835 76828 71128 71112 47412 474201320142015201620172018050k100k150k200k

Charles J. Link
Chairman, Chief Executive & Scientific Officer
Nicholas N. Vahanian
President & Director